TimeLean left
← All coverage gaps
2026-10-23 01:17
Cancer Vaccine Cuts the Risk of Melanoma Recurrence, Merck and Moderna Report
40%40%20%
5 outlets · Left 2 · Center 2 · Right 1
How each side titled it
Each wing's outermost outlet, headline quoted verbatim - framing shows clearest at the edges. Center outlets appear with every other headline below.
Who got there first
each line: one outlet's first article — above the track left · below right · across center
First reported by Just the News (Right); 5 outlets over 24h. The left followed 23h later.
Just the News · +19h Reuters · +19h CNBC · +23h The New York Times · +24h Time
What each side is saying
- TimeLean left
The treatment is still experimental, but results from Moderna and Merck add scientific support for a vaccine-based approach to treating the cancer.
Read at time.com → - The New York TimesLean left
Merck and Moderna released detailed results on an experimental vaccine to treat the skin cancer.
Read at nytimes.com → - ReutersCenter
Moderna sheds about $24 billion as cancer vaccine data triggers 'sell-the-news' retreat Reuters
Read at reuters.com → - Just the NewsRight
The shares dropped by nearly 18% at the close of the day, according to the Wall Street Journal, as apparently positive results still fell short of expectations.
Read at justthenews.com →
Each blurb is the outlet's own feed summary, quoted unedited. Nothing here is generated.
6 articles, newest first · filter by side
location
TimeLean left
A Personalized Cancer Vaccine Lowers Melanoma Recurrence by 42%
Read at time.com →The New York TimesLean left
Cancer Vaccine Cuts the Risk of Melanoma Recurrence, Merck and Moderna Report
Read at nytimes.com →ReutersCenter
Moderna sheds about $24 billion as cancer vaccine data triggers 'sell-the-news' retreat - Reuters
Read at reuters.com →CNBCCenter
Moderna shares plunge after leak of partial cancer vaccine data despite positive results
Read at cnbc.com →ReutersCenter
Merck/Moderna cancer vaccine cuts risk of death or recurrence from melanoma by over 40% - Reuters
Read at reuters.com →Just the NewsRight
Moderna stock plummets after reported leak of disappointing cancer-vaccine data
Read at justthenews.com →Every headline that clustered into this story, newest first. Links go straight to the publisher - no article text is stored here, and the one image is an unmodified copy of the publisher's own thumbnail.